New combo pill tested for long-term safety in teens with mental health conditions
Disease control
ENROLLING_BY_INVITATION
This study is testing the long-term safety of a daily pill called OLZ/SAM (olanzapine plus samidorphan) in 236 teenagers with schizophrenia or bipolar I disorder. Participants have already completed a previous study with the same drug. The goal is to see if the drug is safe and t…
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC